Guías Clínicas 43 • US National Institutes of Diabetes, Digestive, and Kidney Disorders: http://digestive.niddk.nih.gov/ ddiseases/pubs/celiac/ • The Gluten Intolerance Group: http://www.gluten. net/ • Celiac Helpline: www.celiac.co.uk • The Wheat-Free Zone: www.nowheat.com/grfx/ nowheat/index.htm • US National Digestive Disease Clearinghouse (NDDIC): http://digestive.niddk.nih.gov/ddisea-ses/ pubs/celiac/index.htm • OMGE “Ask a Librarian” for Celiac Disease Re-search support: www.omge.org 9. Pautas, servidores y más lecturas 9.1. Pautas de la enfermedad celíaca 1.- National Institutes of Health Consensus Development Conference on Celiac Disease: final statement. June 28-30, 2004. http://consensus.nih.gov/cons/118/118cdc_intro.htm 2.- Agency for Healthcare Research and Quality. Celiac disea-se: summary. Evidence report/technology assessment no. 104. AHRQ Publication Number 04-E029-1, June 2004- 09-14. http://www.ahrq.gov/clinic/epcsums/celiacsum.htm 3.- American Gastroenterological Association medical posi-tion statement: Celiac sprue. Gastroenterology 2001; 120: 1522-1525. Pubmed-Medline. 4.- Ciclitira PJ, King AL, Fraser JS. AGA technical review on celiac sprue. American Gastroenterological Association. Gastroenterology 2001; 120: 1526-1540. Pubmed-Medli-ne. 5.- British Society of Gastroenterology. Interim guide-lines for the management of patients with coeliac disease (revised by Professor P Ciclitira April 2002). http://www.bsg.org.uk/clinical_prac/guidelines/celiac.htm 6.- Children’s Digestive Health and Nutrition Foun-dation/ North American Society for Pediatric Gas-troenterology and Nutrition. Celiac disease. 2004. http://www.naspgn.org/assets/diseaseInfo/pdf/Celiac.pdf 7.- Celiac disease list server. St. Johns Celiac Listserv News-group. To subscribe, send an e-mail to the following ad-dress: listserv@maelstrom.stjohns.edu En el cuerpo de la carta, ponga lo que sigue: SUB CELIAC seguido de su nombre y apellido. Por ejemplo, SUB CELIAC Bob Jones. 9.2. Otras lecturas 1.- Abdulkarim AS, Murray JA. Review article: the diagnosis of coeliac disease. Aliment Pharmacol Ther 2003; 17: 987- 995. Pubmed-Medline. 2.- Arentz-Hansen H, Fleckenstein B, Molberg O, Scott H, Koning F, Jung G, et al. The molecular basis for oat into-lerance in patients with celiac disease. PLoS Med 2004; 1 (1): e1. Pubmed-Medline Pubmed-Central. 3.- Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V, et al. Additional factor in some HLA DR3/ DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 2003; 61: 308-316. Pubmed-Medline. 4.- Catassi C, Ratsch IM, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, et al. Why is coeliac disease endemic in the people of the Sahara? Lancet 1999; 354: 647-648. Pubmed-Medline. 5.- Catassi C, Fanciulli G, D’Appello AR, El Asmar R, Rondina C, Fabiani E, et al. Antiendomysium versus anti-gliadin antibodies in screening the general population for coeliac disease. Scand J Gastroenterol 2000; 35: 732-736. Pubmed-Medline. 6.- Dieterich W, Esslinger B, Schuppan D. Pathomechanisms in celiac disease. Int Arch Allergy Immunol 2003; 132: 98-108. Pubmed-Medline. 7.- Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346: 180-188. Pubmed-Medline. 8.- Fasano A. Celiac disease: how to handle a clinical chame-leon. N Engl J Med 2003; 348: 2568-2570. Pubmed_Me-dline. 9.- Fasano A. European and North American populations should be screened for coeliac disease. Gut 2003; 52: 168- 169. Pubmed-Medline. 10.- Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gas-troenterology 2001; 120: 636-651. Pubmed-Medline. 11.- Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-292. Pubmed-Medline. 12.- Gandolfi L, Pratesi R, Cordoba JC, Tauil PL, Gasparin M, Catassi C. Prevalence of celiac disease among blood donors in Brazil. Am J Gastroenterol 2000; 95: 689-692. Pubmed-Medline. 13.- Green PH, Jabri B. Coeliac disease. Lancet 2003; 362: 383-391. Pubmed-Medline. 14.- Karpati S. Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci 2004; 34: 83-90. Pubmed-Medline. 15.- Kumar PJ. European and North American populations should be screened for coeliac disease. Gut 2003; 52: 170- 171. Pubmed-Medline. 16.- Louka AS, Sollid LM. HLA in coeliac disease: unravel-ling the complex genetics of a complex disorder. Tissue Antigens 2003; 61: 105-117. Pubmed-Medline. 17.- Margaritte-Jeannin P, Babron MC, Bourgey M, Louka AS, Clot F, Percopo S, et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 2004; 63: 562-567. Pubmed-Medline. 18.- Moreno ML, Vazquez H, Mazure R, Smecuol E, Niveloni S, Pedreira S, et al. Stratification of bone fracture risk in patients with celiac disease. Clin Gastroenterol Hepatol 2004; 2: 127-134. Pubmed-Medline. 19.- Mulder CJJ, Bartelsman JFWM. Case finding in coeliac disease seems beneficial, mass screening is still contro-versial. Scand J Gastroenterol in press. GUÍA PRÁCTICA DE LA OMGE: ENFERMEDAD CELÍACA - J. Bai et al. Gastroenterol. latinoam 2010; Vol 21, Nº 1: 34-44
n4-2010
To see the actual publication please follow the link above